Sputnik V Overview
- Headquarters
- Moscow, Ru
- Website
- sputnikvaccine.com
- Industry
- Research
- Employees
- 351
About Sputnik V
Sputnik V is the world’s first registered COVID-19 vaccine with proven 91.6% efficacy, based on a human adenoviral vector platform. Registered in over 70 countries.
Compare Similar Companies to Sputnik V
Johnson & Johnson
Hospitals And Health Care
Pfizer
Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical Manufacturing
Kommersant
Newspaper Publishing
SINOVAC BIOTECH LTD.
Biotechnology Research
Sputnik Media
Media Production
IYNO
Software Development
WIV France
Related company record
GlobalNEST
Multi-signal peer
Russia News
Book And Periodical Publishing